Ameriprise’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-40,705
| Closed | -$608K | – | 4090 |
|
|
2022
Q4 | $608K | Sell |
40,705
-117,987
| -74% | -$1.63M | ﹤0.01% | 3328 |
|
|
2022
Q3 | $1.31M | Sell |
158,692
-3,708
| -2% | -$28.5K | ﹤0.01% | 2983 |
|
|
2022
Q2 | $1.06M | Buy |
+162,400
| New | +$787K | ﹤0.01% | 3093 |
|
|
2020
Q4 | – | Sell |
-39,640
| Closed | -$235K | – | 3904 |
|
|
2020
Q3 | $235K | Buy |
+39,640
| New | +$196K | ﹤0.01% | 3492 |
|
|
2014
Q4 | – | Sell |
-50
| Closed | -$1K | – | 4696 |
|
|
2014
Q3 | $1K | Sell |
50
-146
| -74% | -$1.86K | ﹤0.01% | 5630 |
|
|
2014
Q2 | $4K | Buy |
196
+146
| +292% | +$1.9K | ﹤0.01% | 5029 |
|
|
2014
Q1 | $1K | Hold |
50
| – | – | ﹤0.01% | 5214 |
|
|
2013
Q4 | $1K | Sell |
50
-323
| -87% | -$6.47K | ﹤0.01% | 5032 |
|
|
2013
Q3 | $8K | Hold |
373
| – | – | ﹤0.01% | 5050 |
|
|
2013
Q2 | $9K | Buy |
+373
| New | +$15.9K | ﹤0.01% | 4871 |
|
Ameriprise's AVEO Position: Q1 2023 in Review
Ameriprise sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 40,705 shares — an estimated $608K sold.
Ameriprise first reported a position in AVEO in Q2 2013 and held it in 10 quarters. The position peaked at $1.31M in Q3 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Ameriprise reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Ameriprise sold 40,705 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $608K.
- Ameriprise first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 10 quarters.
- Ameriprise's AVEO Pharmaceuticals, Inc. position peaked at $1.31M in Q3 2022.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Ameriprise's 13F filing for Q1 2023, filed 15 May 2023.